These are three of the seven papers we published in 2024:
Mao, Y.-Q., Jahanshahi, S., Malty, R., Van Ommen, D. A. J., Wan, Y., Ahmed, C., Dahal, S., Lin, F., Mangos, M., Nurtanto, J., Been, T., Christie-Holmes, N., Gray-Owen, S. D., Babu, M., Batey, R. A., Attisano, L., Cochrane, A., & Houry, W. A. “Targeting Protein Homeostasis with Small Molecules as a Strategy for the Development of Pan-Coronavirus Antiviral Therapies” Communications Biology 7:1460 (2024).
Lin, F., Mabanglo, M. F., Zhou, J. L., Binepal, G., Barghash, M. M., Wong, K. S., Gray-Owen, S. D., Batey, R. A., & Houry, W. A. “Structure-Based Design and Development of Phosphine Oxides as a Novel Chemotype for Antibiotics that Dysregulate Bacterial ClpP Proteases” Journal of Medicinal Chemistry 67(17):15131-15147 (2024).
Mao, Y.-Q., Seraphim, T. V., Wan, Y., Wu, R., Coyaud, E., Bin Munim, M., Mollica, A., Laurent, E., Babu, M., Mennella, V., Raught, B., & Houry, W. A. “DPCD is a Regulator of R2TP in Ciliogenesis Initiation Through Akt Signaling” Cell Reports 43(2), 113713, 1-27 (2024). (PDF file)